According to Shanwaishan's announcement, Hunan Xiangjiang Health Venture Capital Partnership, which holds more than 5% of the company's shares, and its co-actor, Hunan Xiangjiang Liyuan Jiankun Venture Capital Partnership, reduced their holdings of the company's shares by a total of 4.82 million shares through bulk transactions, accounting for 1.08% of the company's total share capital. After this change in equity, the total shareholding ratio of the above shareholders was reduced from 6.99% to 5.91%. The current holdings reduction is to fulfill the previously disclosed holdings reduction plan. Currently, the plan has not been implemented, and will not lead to changes in the controlling shareholders and actual controllers of the company.

According to Shanwaishan's announcement, Hunan Xiangjiang Health Venture Capital Partnership, which holds more than 5% of the company's shares, and its co-actor, Hunan Xiangjiang Liyuan Jiankun Venture Capital Partnership, reduced their holdings of the company's shares by a total of 4.82 million shares through bulk transactions, accounting for 1.08% of the company's total share capital. After this change in equity, the total shareholding ratio of the above shareholders was reduced from 6.99% to 5.91%. The current holdings reduction is to fulfill the previously disclosed holdings reduction plan. Currently, the plan has not been implemented, and will not lead to changes in the controlling shareholders and actual controllers of the company.